✦ LIBER ✦

Etiology of Acute Myeloid Leukemia in the Elderly

✍ Scribed by David T. Bowen

Book ID: 117821945
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 252 KB
Volume: 43
Category: Article
ISSN: 1532-8686
DOI: 10.1053/j.seminhematol.2006.01.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute Myeloid Leukemia in the Elderly

✍ Hervé Dombret; Emmanuel Raffoux; Claude Gardin 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Acute myeloid leukemia: Epidemiology and

Acute myeloid leukemia: Epidemiology and etiology

✍ Barbara Deschler; Michael Lübbert 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB

## Abstract Acute myeloid leukemias (AMLs) are infrequent, yet highly malignant neoplasms responsible for a large number of cancer‐related deaths. The incidence has been near stable over the last years. It continuously shows 2 peaks in occurrence in early childhood and later adulthood. With an inci

Acute myeloid leukemia in elderly adults

✍ J. Tucker; A. E. Thomas; W. M. Gregory; T. S. Ganesan; S. T. A. Malik; J. A. L. 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

One hundred and fifteen previously untreated adults aged over 60 years were referred to St Bartholomew's Hospital between 1978 and 1986 for management of acute myeloid leukemia (AML). Twenty-seven patients received symptomatic or palliative treatment only because combination chemotherapy was conside

Treatment of Elderly Acute Myeloid Leuke

Treatment of Elderly Acute Myeloid Leukemia Patients

✍ Gabriela Motyckova; Richard M. Stone 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 171 KB

Acute myeloid leukemia in the elderly: ‘

Acute myeloid leukemia in the elderly: ‘per aspera ad astra’?

✍ Roberto Latagliata; Maria Concetta Petti; Franco Mandelli 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 97 KB

Acute myeloid leukemia in the elderly: b

Acute myeloid leukemia in the elderly: biology and therapeutic strategies

✍ A Pinto; V Zagonel; F Ferrara 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Age represents one of the most important adverse prognostic factors in acute myeloid leukemia (AML). The therapeutic results for patients older than 60 years accrued into clinical trials of intensive chemotherapy are largely unsatisfactory (complete remission rates rarely superior to 50-60%; median